Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1997-07-29
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
424449, A61K 3144, A61K 970
Patent
active
056522444
ABSTRACT:
A method of treating specific forms of cancer with water-insoluble 20(S)-camptothecin compounds with the closed-lactone ring intact and/or derivatives thereof is disclosed. The method includes administering the compounds intramuscularly, orally and transdermally.
REFERENCES:
patent: 4774236 (1988-09-01), Cook et al.
patent: 4894456 (1990-01-01), Wall et al.
patent: 5106742 (1992-04-01), Wall et al.
patent: 5225404 (1993-07-01), Giovanella et al.
Giovanella et al., Science, vol. 246, pp. 1046-1048 (Nov. 24 1989).
Hsiang, Y.-H. et al., Cancer Res. 48: 1722-1726, 1988.
Wani, M.C. et al., J. Med. Chem. 30: 1774-1779, 1987.
Wani, M.C. et al., J. Med. Chem. 29: 2358-2363, 1986.
Hsiang, Y.-H. et al., J. Biol. Chem. 97: 14873-14878, 1985.
Hsiang, Y.-H. et al., Abstract 683 from The American Association for Cancer Research, vol. 29, Mar. 1988.
Wall, M.E. et al., J. Med. Chem. 29: 1553-1555, 1986.
Nelson, W.G. et al., Cancer Res. 47: 3246-3250, 1987.
Hsiang, Y.-H. et al., Cancer Res. 49: 4386-4389, 1989.
Wani, M.C. et al., J. Med. Chem. 30: 2317-2319, 1987.
Giovanella, B.C. et al., Cancer 52: 1146-1152, 1983.
Wani, M.C. et al., J. Med. Chem. 23: 554-560, 1980.
Leibovitz, A. et al., Cancer Res. 36: 4562-4569, 1976.
Fogh, J. et al., in "Human Tumor Cells In Vitro," Fogh, Jr. ed., Plenum Press, New York, 1976, pp. 115-141.
Liu, L.F. et al., Proc. Nat'l. Acad. Sci. USA, 78: 3487-3491, 1981.
Muggla, F.M. et al., Cancer Chemo. Rep. 56: 515-521, 1972.
Gottlieb, J.A. et al., Cancer Chemo. Rep. 54: 461-470, 1970.
Jaxel, C. et al., Cancer Res. 49: 1465-1469, 1989.
Potmesil, M. et al., Cancer Res. 48: 3537-3543, 1988.
Chemical Abstracts, vol. 106(25), Abstract No. 207285z (1987).
Chemical Abstracts, vol. 106(15), Abstract No. 120133z (1987).
Chemical Abstracts, vol.106(15), Abstract No. 11479a (1987).
Chemical Abstracts, vol. 106(13), Abstract No. 95753s (1987).
Chemical Abstracts, vol. 103(9), Abstracts No. 64374c (1985).
Chemical Abstracts, vol. 101, Abstract No. 130677r (1984).
Chemical Abstracts, vol. 101(11), Abstract No. 91322z (1982).
Chemical Abstracts, vol. 101(10), Abstract No. 78770z (1984).
Chemical Abstracts, vol. 100(21), Abstract No. 167724j (1983).
Chemical Abstracts, vol. 100, Abstract No. 139434w (1984).
Chemical Abstracts, vol. 97, Abstract No. 188278b (1982).
Chemical Abstracts, vol. 96(9), Abstract No. 69271p (1981).
Chemical Abstracts, vol. 95(15), Abstract No. 133209h (1981).
Chemical Abstracts, vol. 94(12), Abstract No. 90169e (1980).
Chemical Abstracts, vol. 94(1), Abstract No. 4143n (1980).
Chemical Abstracts, vol. 92(5), Abstract No. 37766e (1980).
Chemical Abstracts, vol. 92(3), Abstract No. 18799b (1980).
Chemical Abstracts, vol. 90(4), Abstract No. 28930k (1979).
Chemical Abstracts, vol. 90(3), Abstract No. 22857v (1979).
Chemical Abstracts, vol. 84, Abstract No. 115629p (1976).
Derwent 87-179979/25 (1987).
Nicholas et al., J. Med. Chem., vol. 33, No. 3, pp. 972-978, 1990.
Ohro et al., Proc. Ann. Meet. Am. Soc. Clin. Oncol., 8: A1019, 1989.
Hertzberg et al., J. Med. Chem., vol. 32(3), pp. 715-720, 1989.
Hsiang et al., Proc. Ann. Meet. Am. Assoc. Cancer Res., 30: A2476, 1989.
Hertzberg et al., Proc. Ann. Meet. Am. Assoc. Cancer Res., 30: A2485, 1989.
Pommier et al., Proc. Ann. Meet. Am. Assoc. Cancer Res., 29: A1080, 1988.
Lin et al., Yao Hsueh Hsueh Pao, vol. 23(3), pp. 186-188, 1988.
Ronman et al., Journal of Labelled Compounds and Radiopharmaceuticals, vol. 18(3), pp. 319-329, 1981.
Danishefky et al., J. Org. Chem., vol. 39(28), pp. 3430-3432, 1974.
Plattner et al., J. Org. Chem., vol. 39(3), pp. 303-311, 1974.
Plattner et al., J. Amer. Chem. Soc., vol. 94(24), pp. 8615-8616, 1972.
Govindachari et al., "9-Methoxycaptothecin: A new Alkaloid from Mappie foetida Miers," pp. 453-454, 1974.
Giovanella Beppino C.
Hinz Hellmuth R.
Kozielski Anthony J.
Stehlin John S.
Goldberg Jerome D.
The Stehlin Foundation for Cancer Research
LandOfFree
Method for treating cancer with water-insoluble S-camptothecin o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating cancer with water-insoluble S-camptothecin o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating cancer with water-insoluble S-camptothecin o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-633988